Relay Medical & Fio to Bring Fionet Mobile COVID-19 Testing & Tracking Platform to Private School Campus and Hockey Rink in the Greater Toronto Area
Toronto, Ontario--(Newsfile Corp. - November 18, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and Fio Corporation ("Fio"), together Fionet Rapid Response Group ("FRR"), report on an agreement with King Heights Academy and Paramount Ice in the Greater Toronto Area to bring the Fionet COVID-19 mobile testing and tracking platform to their facilities for pilot deployments.
King Heights Academy has engaged FRR to assist in providing technologies, services and protocols for safer attendance and participation in school curriculum at their campuses. Paramount Ice is proactively pursuing potential solutions for improving protocols for safer attendance and participation in activities at their Hockey rink locations in the GTA. FRR will work with the two partners to first establish pilot demonstrations of an FRR solution at their facilities and then for full deployment.
The Fionet system combined with approved lateral flow rapid diagnostic tests (RDTs) offers a complete COVID-19 community screening and surveillance solution that can effectively test 20-40 people per hour with lab-based equivalency. The system can be deployed to increase the confidence and safety of citizens at home, work and recreation during the COVID-19 pandemic by organizing and executing rapid diagnostic testing in community-based settings as part of surveillance and screening testing programs.
"We're excited to work with Fio and Relay to help provide COVID-19 screening at our schools and hockey rinks using the Fionet platform. Pre-COVID we saw a half a million visitors a year and now we are at a fraction of that level. We want to be proactive and do everything we can to keep our students, employees, members, trainees and guests safe so that everyone can get back to a semblance of normal life, and this requires more testing," said Dave Yarmus, Director and Partner.
"These deployments, we believe, will really showcase the great benefits Fionet offers for distributed community-based testing and tracking to help open up businesses. We are excited to work together with King Heights Academy and Paramount Ice to bring onsite testing as soon as possible to their Toronto locations," said Dr. Michael Greenberg, CEO of Fionet Rapid Response Group.
The pilot engagements include four deployment zones for mobile screening and tracking of COVID-19. FRR will develop protocols and workflows as a guide with the Clients being able to modify the protocols based on their own input from Clinical experts and local health authorities. FRR's deployment will comply with all local, provincial, and federal requirements in coordination with public health directives. Implementation and timing will depend on the accessibility of RDTs by government authorities and all necessary approvals.
Home, Work, Play
In the fight against COVID-19, mass community-based testing is needed to facilitate a safe return to work, school and everyday life. With Fionet, it is possible to dramatically scale up COVID-19 testing into community-based settings including workplaces, schools and public places to help prevent the spread of the virus. This life-changing technology helps to reopen the economies and schools with confidence, and ultimately save both lives and livelihoods.
FRR is also in negotiation with several other leading healthcare organizations around the world to pilot and/or deploy Fionet to support rapid testing programs for COVID-19 and other infectious diseases.
**The Companies are not making any express or implied claims that their product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.
About King Heights Academy and Paramount Ice
King Heights Academy provides a unique educational experience for children in Pre-K through Secondary School in its two campuses in Woodbridge and Thornhill. Its academic programs interweave the provincial curriculum and International Baccalaureate Primary Years Program to provide safe and collaborative tools and create authentic learning experiences and global interactions for our students. The academic programs are enhanced by our elite sports programs, each designed to provide our student athletes with a well-rounded approach to their personal, academic, and athletic success.
Paramount Ice is one of the most unique ice skating and hockey arenas in the Toronto and York Region, featuring 2 state of the art facilities. Paramount Sports Management is an industry leader in sports, academics, and events. Paramount is committed to helping its athletes and partners push themselves to reach their full potential in their academic and athletic endeavors.
Paramount Ice believes that sport is a powerful tool to create social change, to promote healthy living and to bring a community together, and strives to provide a safe, fun, inclusive, and challenging environment. Paramount offers 3 NHL ice rinks, 2 training rinks and a shooting lane, 2 high performance gyms which are used for ice hockey, skating programs and ice rentals, figure skating, development clinics, private training and youth and adult hockey leagues. More than 40,000 visitors per month frequented Paramount's facilities prior to COVID.
About Fio Corporation
Fio Corporation, privately held and headquartered in Toronto, developed and markets the world's first integrated guidance & tracking IT platform for decentralized healthcare settings, a new category of solution that raises healthcare quality and lowers healthcare costs. The platform enables average healthcare workers in clinics to deliver a new level of quality-controlled diagnostic testing and case management. Simultaneously, as an automated by-product of its clinical use, the platform captures and provides unprecedented frontline data to remote supervisors and stakeholders, enabling real-time remote tracking, insight distribution, and intervention. Fio operates globally in partnership with local distribution, service, and support organizations and also partners with other companies that license its technologies.
About Relay Medical Corp.
Relay Medical is a MedTech innovation Company headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics and AI data science sectors.
W. Clark Kent
Relay Medical Corp.
Office. 647-872-9982 ext. 2
TF. 1-844-247-6633 ext. 2
EU Investor Relations
Office. +49 (0) 177 774 2314
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the Company's technologies described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at www.sedar.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68500